Latest News

Corcept Therapeutics announced in July that it would report its second-quarter 2026 results and host a corporate update call, while analysts recently lifted their full-year earnings estimates and assigned the company a Zacks Rank of #2. What stands out is how Corcept’s sharply improved earnings outlook and analyst sentiment contrast with weaker returns across the broader Medical and Medical – Drugs groups. With this strengthened earnings outlook in focus, we’ll now examine how the latest...

Earlier this week, Adaptive Biotechnologies was upgraded by analysts following upward revisions to earnings estimates, including an expected quarterly loss of US$0.13 per share and forecast revenue of US$66.27 million for the June 2026 quarter. The company’s decision to raise its 2026 MRD revenue guidance to a range of US$260 million to US$270 million highlights how MRD has become the central engine of its business outlook. We’ll now explore how the upgraded earnings expectations and higher...

UPM-Kymmene Oyj (HLSE:UPM) has put fresh numbers on the table for Q2 2026, with revenue of €2.4 billion and basic EPS of €0.29, against a trailing twelve month picture showing revenue of €9.5 billion and EPS of €1.18. Over recent quarters, the company has seen revenue hold around the €2.3 billion to €2.6 billion range while basic EPS moved from €0.13 in Q2 2025 to €0.49 in Q4 2025 and €0.29 in the latest quarter. This sets up a results season in which improving net profit margins and faster...

Bystronic (SWX:BYS) has opened H1 2026 with trailing 12 month revenue of CHF 611.5 million and a net loss of CHF 41.4 million, setting a cautious tone around how efficiently recent sales are translating into earnings. The company has seen half yearly revenue move from CHF 317.4 million in H2 2024 to CHF 304.6 million in H1 2025 and CHF 308.6 million in H2 2025, while net losses over those periods shifted between CHF 46.8 million, CHF 12.9 million and CHF 16 million. Investors are likely to...

McCormick stock has retreated sharply over the past few years, yet on most valuation checks it now screens as attractively priced rather than clearly expensive or cheap relative to its fundamentals. Shareholders have seen the stock fall about 39.4% over the past 3 years, which puts recent price action under scrutiny for anyone reassessing McCormick's long term appeal. The planned combination with Unilever's Foods business and a future secondary London listing can reshape how investors think...

Vita Coco Company stock has delivered a strong 161.5% return over the past three years, yet its valuation signals are split, with a Discounted Cash Flow (DCF) view pointing to upside while earnings based multiples suggest the shares are priced rich. Over three years, Vita Coco Company has returned 161.5%, which puts more weight on whether today’s price still leaves room above intrinsic value. Recent acquisitions and expectations for higher earnings can support the DCF based intrinsic value...

Meko (OM:MEKO) has put fresh numbers on the table for Q2 2026, reporting revenue of SEK4.6b and basic EPS of SEK1.42, with net income of SEK79m framing the latest quarterly snapshot. The company has seen revenue move between SEK4.5b and SEK4.7b over the past six reported quarters, while quarterly EPS has ranged from a loss of SEK0.18 to a profit of SEK1.42. This gives investors a clear view of how earnings have tracked through recent swings in profitability. With analysts focused on earnings...

Global markets are wrestling with inflation trends, shifting central bank policies and energy prices hovering around key levels like $100 Brent crude. In this kind of backdrop, many investors are looking for companies that analysts expect to grow earnings solidly over the next 3 years while still keeping balance sheets in acceptable shape. That is exactly what the Healthy high growth potential screener focuses on, blending earnings growth expectations with basic financial strength checks...

BE Semiconductor Industries (ENXTAM:BESI) has released its Q2 2026 numbers with revenue of €249.9 million and basic EPS of €1.11, setting the tone for another data heavy update. The company has seen revenue move from €148.1 million in Q2 2025 to €249.9 million in Q2 2026, while quarterly basic EPS over the same periods shifted from €0.40 to €1.11. This gives investors clear evidence of how the top and bottom line are tracking year on year. With net profit margins over the last twelve months...

MetLife (MET) is back in focus after two separate developments: an expanded bereavement support partnership in Ireland and the completion of a mixed use real estate project in Tampa, which have prompted fresh interest in the stock. See our latest analysis for MetLife. Against this backdrop, MetLife’s share price has moved to $92.54, with a 30 day share price return of 5.12% and a 90 day share price return of 19.10%, while the 1 year total shareholder return of 22.53% and 5 year total...

Trade Desk stock has endured a steep reset, with the share price down about 80.3% over the past three years, yet the broader valuation checks still lean toward the shares looking cheap rather than fully priced in. The roughly 80.3% share price decline over three years signals that sentiment around Trade Desk has shifted sharply, even as the business continues to invest in its advertising platform. Recent moves to deepen retail media data in Japan and add experienced leaders in areas like...

Fresh from reporting its H1 2026 results, Bellevue Group (SWX:BBN) is coming off a trailing twelve month stretch where revenue totalled CHF 53.91 million and basic EPS reached CHF 0.319, alongside trailing earnings growth of 81.3% year on year. Over the past reported halves, the company has seen revenue move from CHF 33.685 million in H2 2024 to CHF 25.154 million in H1 2025 and CHF 27.653 million in H2 2025, while basic EPS shifted from CHF 0.130 to CHF 0.014 and then CHF 0.128 over the same...

Cinemark Holdings recently attracted attention as analysts projected a year-over-year earnings increase on higher revenues for its latest reported quarter, with Zacks highlighting an Earnings ESP of 6.40% and a Rank #3 status. This gap between the Most Accurate Estimate and the broader consensus suggests analysts see a meaningful chance of Cinemark outperforming expectations, sharpening focus on how its operations are tracking. Now we’ll explore how the prospect of an earnings beat and...

Dassault Systèmes (ENXTPA:DSY) has reported Q2 2026 revenue of €1,555.8 million with basic EPS of €0.24, backed by trailing twelve month revenue of €6.2 billion and EPS of €1.00 that reflect earnings growth of 16.6% over the past year. Over recent quarters, revenue has moved from €1,521.6 million and EPS of €0.17 in Q2 2025 to €1,555.8 million and EPS of €0.24 in Q2 2026. Trailing twelve month EPS has progressed from €0.86 to €1.00 as margins improved from 18% to 21.3%. That combination of...

Pihlajalinna Oyj (HLSE:PIHLIS) has reported Q2 2026 revenue of €136.7 million with basic EPS of €0.01, alongside trailing twelve month EPS of €1.06 on revenue of €575.1 million and net income of €24.5 million. The company has seen quarterly revenue move from €175.5 million in Q2 2025 to €136.7 million in Q2 2026, while basic EPS shifted from €0.39 to €0.01 over the same period. This sets up a quarter where investors are likely to focus closely on how margins are holding up against the longer...

UniCredit (BIT:UCG) has just posted its Q2 2026 scorecard, with revenue at €6.3b and net income at €2.9b, setting the tone for how the rest of the year might look for shareholders watching earnings power and capital returns. The company has seen quarterly revenue move in a tight band over recent periods, from €6.9b in Q2 2025 and €5.7b in Q4 2025 to €6.9b in Q1 2026 and now €6.3b. Net income tracked from €3.3b in Q2 2025 through €2.0b in Q4 2025 to €3.2b in Q1 2026 and €2.9b this quarter,...

Givaudan (SWX:GIVN) has put fresh numbers on the table for H1 2026, with revenue of CHF 3.8b and basic EPS of CHF 51.46 anchoring the latest set of results. The company has seen recent revenue move between CHF 3.6b and CHF 3.9b across the last three half year periods, while basic EPS has ranged from CHF 51.46 to CHF 64.18. This gives investors a clear view of how the top and bottom lines have tracked through the past year. With a trailing twelve month net profit margin of 12.9%, down from...

With UK government debt above 95% of GDP and investors closely watching John Healey’s fiscal plans, bond market confidence is back in the spotlight. That matters for large, established UK stocks, where borrowing costs, policy clarity and any supply side reforms can all feed into valuations and volatility. This article looks at how those cross currents connect to three UK large cap stocks from our Blue Chip Stocks screener that appear positively exposed to the latest policy signals. You will...

Acast (OM:ACAST) opened Q2 2026 with revenue of SEK775.6 million and basic EPS of SEK0.15, while the trailing twelve month figures sit at SEK2.8 billion in revenue and SEK0.57 in basic EPS. This gives investors a clearer read on earnings power over a longer stretch. The company has seen quarterly revenue move from SEK606.7 million in Q2 2025 to SEK775.6 million in Q2 2026, with basic EPS shifting from a loss of SEK0.44 to a profit of SEK0.15 over the same period. This sets up a story where...

Rexford Industrial Realty, Inc. reported past second quarter 2026 results showing sales of US$243 million, revenue of US$245.51 million, and a net loss of US$504.15 million driven by non-cash impairments, alongside funds from operations of US$0.63 per share that exceeded consensus estimates. Alongside these mixed operating metrics, the company unveiled a new US$1.0 billion stock repurchase program and raised its 2026 disposition guidance to US$1.5–2.0 billion as it repositions its portfolio...

STMicroelectronics (ENXTPA:STMPA) has reported Q2 2026 revenue of US$3.5 billion and basic EPS of US$0.25, with net income of US$222 million giving investors a clear snapshot of its latest quarter. The company has seen quarterly revenue move from US$2,766 million in Q2 2025 to US$3,487 million in Q2 2026, while basic EPS has shifted from a loss of US$0.11 to a profit of US$0.25 over the same period. This sets the stage for a closer look at how top line and EPS trends are feeding through to...

STEICO (XTRA:ST5) has opened H1 2026 earnings season with trailing 12 month revenue of about €384.7 million and net income of €15.1 million, setting a clear reference point against a current share price of €18.60. Over recent periods the company has seen half yearly revenue move between €185.7 million and €199.2 million, while net income shifted from a loss of €0.5 million in H2 2024 to €10.6 million in H1 2025 and €7.2 million in H2 2025. This gives investors a clear view of how the top and...

Global markets are juggling sticky inflation, shifting tariffs and uneven growth, so many investors are looking for companies where analysts still see clear earnings expansion and solid balance sheets. That is exactly what the Healthy high growth potential screener aims to highlight, focusing on stocks where earnings are expected to grow strongly over the next 3 years and financial foundations look sound. With purchasing manager data pointing to mixed but resilient activity and energy costs...

Stille (OM:STIL) has released its Q2 2026 numbers, with revenue at 186.9 million SEK and basic EPS of 2.29 SEK, while trailing 12 month EPS stands at 8.08 SEK on revenue of 679.6 million SEK. The company has seen quarterly revenue move from 124.7 million SEK in Q2 2025 to 138.8 million SEK in Q3 2025, 174.9 million SEK in Q4 2025, 179.1 million SEK in Q1 2026 and now 186.9 million SEK in Q2 2026, with basic EPS over the same stretch ranging from 1.11 SEK to 3.37 SEK before landing at 2.29 SEK...